Perrigo (NASDAQ:PRGO) Director Ran Gottfried unloaded 2,275 shares of the stock on the open market in a transaction that occurred on Monday, November 4th. The stock was sold at an average price of $143.36, for a total value of $326,144.00. Following the completion of the transaction, the director now directly owns 11,609 shares in the company, valued at approximately $1,664,266. The sale was disclosed in a filing with the SEC, which can be accessed through this link.
Perrigo (NASDAQ:PRGO) traded up 0.93% during mid-day trading on Wednesday, hitting $143.82. The stock had a trading volume of 301,695 shares. Perrigo has a one year low of $98.79 and a one year high of $144.03. The stock’s 50-day moving average is $129.3 and its 200-day moving average is $123.8. The company has a market cap of $13.562 billion and a price-to-earnings ratio of 30.06.
Perrigo (NASDAQ:PRGO) last issued its quarterly earnings data on Thursday, October 31st. The company reported $1.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.40 by $0.12. The company had revenue of $933.00 million for the quarter, compared to the consensus estimate of $900.10 million. During the same quarter in the previous year, the company posted $1.27 earnings per share. The company’s revenue for the quarter was up 21.3% on a year-over-year basis. On average, analysts predict that Perrigo will post $6.57 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which is scheduled for Tuesday, December 17th. Investors of record on Friday, November 29th will be given a dividend of $0.09 per share. This represents a $0.36 dividend on an annualized basis and a yield of 0.25%.
A number of research firms have recently commented on PRGO. Analysts at Barrington Research raised their price target on shares of Perrigo from $142.00 to $174.00 in a research note to investors on Monday. They now have an “outperform” rating on the stock. Separately, analysts at UBS AG raised their price target on shares of Perrigo from $140.00 to $160.00 in a research note to investors on Monday. They now have a “buy” rating on the stock. Finally, analysts at Stifel Nicolaus raised their price target on shares of Perrigo from $145.00 to $150.00 in a research note to investors on Friday, November 1st. They now have a “buy” rating on the stock. Six research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. Perrigo presently has a consensus rating of “Buy” and a consensus price target of $138.27.
Perrigo Company is a global healthcare supplier that develops, manufactures and distributes over-the-counter (NASDAQ:PRGO) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products and active pharmaceutical ingredients (API).
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.